Atlas Trials

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

Clinical trial NCT05528887 · UNKNOWN

Trial details

NCT number
NCT05528887
Sponsor
The Affiliated People's Hospital of Ningbo University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed/Refractory Hematological MalignanciesLymphomaMyelomaLeukemia
Start date
2021-09-16
Primary completion
2024-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.